SecBot SecBot
SC 13G/A ·Filed Oct 7, 2026

SRZN

Surrozen, Inc./DE
NEUTRAL
Impact 4/10
Horizonweeks Processed19d 1h ago SEC0001213900-26-107661
Passive stake amendment
Actionable Insight • Neutral

Boxer Capital's 11.6% passive stake signals institutional interest in Surrozen, but as a 13G filer, they are not seeking control. Monitor for any future conversion to 13D (activist intent) or additional accumulation.

DirectionNeutral
Confidencemedium
Horizonweeks
Latest settled — T+5d
SRZN ▼ -10.37% at T+5d
NEUTRAL call -10.37% · α vs SPY -10.09% · entry $27.97 → $25.07
Next anchor: T+20d in 8d
Latest observation: T+11 -12.09% FF3 residual α
Entry = T+0 close
Oct 7, 2026
via day close
T+1d
+6.15%
call +6.15% · α +5.55%
$29.69
settled 19d ago
T+5d
-10.37%
call -10.37% · α -10.09%
$25.07
settled 13d ago
T+20d
Pending
in 8d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

Boxer Capital Management, LLC filed an amended Schedule 13G disclosing a 11.6% passive stake in Surrozen, Inc. as of September 30, 2026, representing 1,360,683 shares. This is a new filing from Boxer Capital (not previously disclosed in the cross-filing context), indicating a significant new institutional position in the micro-cap biotech.

Key Financial Metrics

Stake
11.6%
Investor
Boxer Capital Management, LLC

Key Facts

  • Boxer Capital Management, LLC and related entities beneficially own 1,360,683 shares of Surrozen common stock as of September 30, 2026.
  • The stake represents 11.6% of shares outstanding based on 11,753,558 shares outstanding as of August 4, 2026.
  • Boxer Capital certifies the shares were acquired and held in the ordinary course of business, not for control purposes (passive investor).
  • This is a new filing by Boxer Capital — no prior Boxer Capital 13G appears in the cross-filing context.

Financial Impact

11.6% stake valued at approximately $1.36 million based on share count; no transaction price disclosed.

ownership_percentage

Risk Factors

  • Boxer Capital could sell shares without notice, reducing the overhang.
  • Surrozen is a micro-cap biotech with limited liquidity — large positions may be difficult to exit.
  • The 11.6% stake is based on an August 2026 share count; actual dilution or buybacks may have changed the percentage.

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0001213900-26-107661
Document: 0001213900-26-107661-index.html0001213900-26-107661
Document: 0001213900-26-107661.txt0001213900-26-107661
11 reports for SRZN
Performance horizon
67% Hit rate @ T+5 2 of 3 directional calls Went positive at some point 4 of 4 best @ T+60▲ +7.00%Mar 23, 2026
Filters
Rows
Reports for SRZN — sortable, filterable
TypeNow
Oct 22, 2026
4d ago
SC 13D/A
NEUTRAL ★ 4/10
$25.48awaiting T+5—$25.48 (−0.00%)
Oct 20, 2026
6d ago
8-K
BULLISH ★ 6/10
$25.32awaiting T+5—$25.48 (+0.63%)
Oct 20, 2026
6d ago
Press Release
MIXED ★ 6/10
$25.32awaiting T+5—$25.48 (+0.63%)
Oct 7, 2026
19d ago
SC 13G/A
NEUTRAL ★ 4/10
$27.97 $25.07▼ −10.37%▼ −10.09%$25.48 (−8.90%)
Oct 2, 2026
24d ago
8-K
BULLISH ★ 7/10
$29.32 $29.69▲ +1.26%▲ +0.10%$25.48 (−13.10%)
Oct 2, 2026
24d ago
Press Release
BULLISH ★ 6/10
$29.32 $29.69▲ +1.26%▲ +0.10%$25.48 (−13.10%)
Oct 1, 2026
25d ago
SC 13G
NEUTRAL ★ 4/10
$29.32 $29.69▲ +1.26%▲ +0.10%$25.48 (−13.10%)
Aug 7, 2026
11w ago
25-NSE
NEUTRAL ★ 3/10
$25.09 $23.78▼ −5.22%▼ −5.17%$25.48 (+1.55%)
May 4, 2026
25w ago
Insider Cluster
NEUTRAL ★ 2/10
$32.07 $29.28▼ −8.70%▼ −11.64%$25.48 (−20.55%)
Mar 23, 2026
31w ago
S-3
BEARISH ★ 7/10
$25.00 $29.13▼ −16.52%▼ −16.94%$25.48 (−1.92%)
Showing 10 of 11

US Market Status

Market Closed — Opens Wed (12h 41m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 7, 2026